X4 Pharmaceuticals, Inc Logo

X4 Pharmaceuticals, Inc

Developing and commercializing novel therapies for rare diseases of the immune system.

XFOR | US

Overview

Corporate Details

ISIN(s):
US0428731097 (+1 more)
LEI:
Country:
United States of America
Address:
61 NORTH BEACON STREET, 2134 BOSTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

X4 Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies. The company is dedicated to advancing treatments for patients with rare diseases of the immune system, addressing significant unmet medical needs in conditions such as chronic neutropenia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all X4 Pharmaceuticals, Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for X4 Pharmaceuticals, Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for X4 Pharmaceuticals, Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DONGSUNG PHARMACEUTICAL CO.,LTD Logo
A Korean firm making pharmaceuticals, cosmetics, and popular hair care products for over 60 years.
South Korea
002210
DONGWHA PHARM.CO.,LTD Logo
Develops, manufactures, and sells a diverse portfolio of healthcare products globally.
South Korea
000020
Dottikon ES Holding AG Logo
Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.
Switzerland
DESN
Double Bond Pharmaceutical International AB Logo
Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.
Sweden
DBP B
DR REDDYS LABORATORIES LTD Logo
Global pharma firm providing affordable generics, APIs, and medicines to patients worldwide.
United States of America
RDY
Develops & commercializes PET/CT tracers for diagnosing cancer & neurological disorders.
South Korea
176750
Dx & Vx Co., Ltd. Logo
Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.
South Korea
180400
DYNAVAX TECHNOLOGIES CORP Logo
Biopharma firm developing novel vaccines, like its adult hepatitis B vaccine, with adjuvant tech.
United States of America
DVAX
Dyne Therapeutics, Inc. Logo
Developing targeted therapies for genetic neuromuscular diseases via its FORCE™ platform.
United States of America
DYN
Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.
South Korea
044960

Talk to a Data Expert

Have a question? We'll get back to you promptly.